The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10180 malaria professionals are enjoying the free benefits of MalariaWorld today

GSK; MMV; malaria; vivax; tafenoquine

Press Release: GSK submits US regulatory application for single-dose tafenoquine for Plasmodium vivax malaria

December 1, 2017 - 11:25 -- Malaria World

Issued: Tuesday 28 November 2017, London UK; Geneva, Switzerland

 

Regulatory milestone affirms GSK's strong commitment and scientific capabilities to fighting infectious diseases

Subscribe to RSS - GSK; MMV; malaria; vivax; tafenoquine